Company news
Ambu A/s Class B (OMXCOP:AMBU_B) news
Every Ambu A/s Class B press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
AMBU_B: Endoscopy Solutions growth offsets A&PM headwinds; guidance narrowed, share buyback expanded
May 6, 2026
Ambu Share Buyback Program Ends
February 12, 2026
AMBU_B: Strong Q1 growth in endoscopy and urology, with EBIT margin on track despite tariff and FX headwinds
February 4, 2026
AMBU_B: Double-digit growth and innovation drive global endoscopy leadership ambitions
January 14, 2026
Georg Fischer, Hypoport, Team Internet Group
November 14, 2025
AMBU_B: Strong double-digit growth and margin expansion, with robust outlook despite FX and tariff headwinds
November 5, 2025
Ambu A/S: Quarterly Trading Report 2025 Q3
October 3, 2025
AMBU_B: Ambitious strategy aims for global endoscopy leadership, 11%-13% CAGR, and 20%+ EBIT margin
October 1, 2025
AMBU_B: Strong Q3 growth and raised guidance, despite FX and working capital headwinds
August 22, 2025
Ambu A/S: Quarterly Trading Report 2024 Q4
July 14, 2025
Ambu A/S: Quarterly Trading Report 2025 Q2
July 7, 2025
Ambu rises as FDA issues import alerts on rival devices
June 25, 2025
Ambu Obtains FDA Clearance For Single-Use Flexible Cysto-Nephroscopy Solution
June 19, 2025
Ambu A/S: Annual Trading Report 2024
June 18, 2025
Ambu A/S: Quarterly Trading Report 2025 Q1
June 13, 2025
AMBU_B: Strong Q2 growth and margin, guidance reaffirmed amid tariff and currency headwinds
May 7, 2025
AMBU_B: Strong Q1 growth and margin expansion led to upgraded guidance and robust outlook
January 30, 2025
AMBU_B: Raised guidance after strong Q1; endoscopy leads growth with new launches and operational gains
January 15, 2025
AMBU_B: Strong revenue and margin growth in FY 2023/24, with robust outlook for 2024/25
November 5, 2024
AMBU_B: Q3 saw 15% organic growth, margin gains, and strong cash flow, with upgraded full-year guidance
August 30, 2024